| abstract |
This invention is directed to compounds of formula 1 (I): (see formula (I)) wherein n, m Y, R1, R2, R3, R4 and R5 are described herein as isolated stereoisomers or mixtures thereof, or as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising the compounds of formula (I); and methods of using the compounds and pharmaceutical compositions to treat diseases or conditions associated with JAK2 activity. |